1.            Khayat, A. et al. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel. Isr. J. Health Policy Res. 13, (2024).

2.            Wu, H. et al. Exposome Profiling of Environmental Pollutants in Seminal Plasma and Novel Associations with Semen Parameters. Environ. Sci. Technol. 58, 13594–13604 (2024).

3.            Cui, Y. et al. Heated tobacco product marketing: a mixed-methods study examining exposure and perceptions among US and Israeli adults. Health Educ. Res. 39, 375–397 (2024).

4.            Abu Ahmad, W., Nirel, R., Barges, S., Jolles, M. & Levine, H. Meta-analysis of fine particulate matter exposure during pregnancy and birth weight: Exploring sources of heterogeneity. Sci. Total Environ. 934, (2024).

5.            Abroms, L. C. et al. Industry marketing of tobacco products on social media: case study of Philip Morris International’s IQOS. Tob. Control 33, 518–524 (2024).

6.            Tsaitlin-Mor, L. et al. Long-term Risk for Type 1 Diabetes and Obesity in Early Term Born Offspring: A Systematic Review and Meta-Analysis. J. Clin. Endocrinol. Metab. 109, 1393–1401 (2024).

7.            Weinreb, A., Ludwin, A. & Levine, H. The complicated ART of finding consensus on family-building health policy: a comment on the IFFS consensus document. Hum. Reprod. Update 30, 131–132 (2024).

8.            Khayat, A. et al. IQOS news media coverage in Israel: A comparison across three subpopulations. Tob. Control (2024) doi:10.1136/tc-2023-058422.

9.            Abroms, L. C. et al. Impact of exposures to Heated Tobacco Products in the media and through social connections on product perceptions and use. Tob. Prev. Cessat. 10, (2024).

10.          LoParco, C. R. et al. Driving under the influence of cannabis versus alcohol: A mixed-methods study examining perceptions and related risk behaviors among US and Israeli adults. Addict. Behav. 148, (2024).

11.          Shiri, S. et al. Psychological Health in Late Effects of Poliomyelitis: Ten-Year Follow-Up. Healthc. 11, (2023).

12.          Duan, Z. et al. Health warning labels on heated tobacco products and their impact on use intentions and risk perceptions: a cross-sectional study of adult tobacco users in the US and Israel. Isr. J. Health Policy Res. 12, (2023).

13.          Cui, Y. et al. Theory-based correlates of cannabis use and intentions among US and Israeli adults: a mixed methods study. Subst. Abus. Treat. Prev. Policy 18, (2023).

14.          Ginzburg, A. et al. Timing, extent and outcomes of public health measures in the first wave of the COVID-19 pandemic in Israel and a comparative analysis by socioeconomic indices. Isr. J. Health Policy Res. 12, (2023).

15.          Duan, Z. et al. IQOS Marketing Strategies and Expenditures in the United States From Market Entrance in 2019 to Withdrawal in 2021. Nicotine Tob. Res. 25, 1798–1803 (2023).

16.          Duan, Z. et al. The impacts of electronic cigarette health warning labels on use intentions and perceptions: A cross-sectional study of US and Israeli adults who use tobacco. J. Public health Res. 12, (2023).

17.          Ahmad, W. A. et al. Association between ambient particulate matter and preterm birth stratified by temperature: A population-based pregnancy cohort study. Int. J. Hyg. Environ. Health 254, (2023).

18.          Kamin-Friedman, S., Levine, H., Davidovitch, N., Troen, A. M. & Yang, Y. T. Israel’s judicial overhaul: a threat to the Health in All Policies approach. Lancet 402, 689–690 (2023).

19.          Bar-Zeev, Y. et al. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers. Tob. Control 32, E198–E204 (2023).

20.          Berg, C. J. et al. IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation. Tob. Control 32, 418–427 (2023).

21.          Nirel, R. et al. Maternal exposure to particulate matter early in pregnancy and congenital anomalies in offspring: Analysis of concentration-response relationships in a population-based cohort with follow-up throughout childhood. Sci. Total Environ. 880, (2023).

22.          Berg, C. J. et al. Impact of different health warning label and reduced exposure messages in IQOS ads on perceptions among US and Israeli adults. Prev. Med. Reports 33, (2023).

23.          Levine, H. et al. Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries. Hum. Reprod. Update 29, 157–176 (2023).

24.          Troen, A. M. et al. Israel decides to cancel sweetened beverage tax in setback to public health. Lancet 401, 553–554 (2023).

25.          Levine, H. et al. IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel. Int. J. Environ. Res. Public Health 20, (2023).

26.          Wang, Y. et al. Profiles of tobacco product use and related consumer characteristics in the US and Israel: A multiple-group latent class analysis. Glob. Public Health 18, (2023).

27.          Dopelt, K. et al. Simulation as a key training method for inculcating public health leadership skills: a mixed methods study. Front. Public Heal. 11, (2023).

28.          Endevelt, R. et al. Challenges and obstacles implementing evidence-based food fortification policy in a high-income country. Front. Public Heal. 11, (2023).

29.          Bashkin, O. et al. Identifying the Gaps Between Public Health Training and Practice: A Workforce Competencies Comparative Analysis. Int. J. Public Health 67, (2022).

30.          Akinwumi, A. I. et al. Strong primary care services, an important feature of primary health care: What can Nigeria learn from Israel? Front. Public Heal. 10, (2022).

31.          Elbaz, D., Zeev, Y. B., Berg, C. J., Abroms, L. C. & Levine, H. Proximity of IQOS and JUUL points of sale to schools in Israel: a geospatial analysis. Tob. Control 31, E156–E161 (2022).

32.          Duan, Z. et al. Correlates of Perceptions, Use, and Intention to Use Heated Tobacco Products Among US Young Adults in 2020. Nicotine Tob. Res. 24, 1968–1977 (2022).

33.          Joyal-Desmarais, K. et al. How well do covariates perform when adjusting for sampling bias in online COVID-19 research? Insights from multiverse analyses. Eur. J. Epidemiol. 37, 1233–1250 (2022).

34.          Zohar, T., Negev, M., Sirkin, M. & Levine, H. Trust in COVID-19 policy among public health professionals in Israel during the first wave of the pandemic: a cross-sectional study. Isr. J. Health Policy Res. 11, (2022).

35.          Berg, C. J. et al. Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults. Tob. Control 33, 69–77 (2022).

36.          Khayat, A. et al. PMI’s IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups. Tob. Control 33, 54–61 (2022).

37.          Khayat, A. et al. IQOS and cigarette advertising across regulatory periods and population groups in Israel: a longitudinal analysis. Tob. Control 33, 3–10 (2022).

38.          Björndahl, L. et al. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology. Hum. Reprod. 37, 2497–2502 (2022).

39.          Duan, Z. et al. ‘It’s like if a vape pen and a cigarette had a baby’: a mixed methods study of perceptions and use of IQOS among US young adults. Health Educ. Res. 37, 364–377 (2022).

40.          Vishnevsky, G. et al. Different Factors Are Associated With Sex Hormones and Leydig Cell Function in Israelis and Palestinians in Jerusalem. Am. J. Mens. Health 16, (2022).

41.          Ahmad, W. A. et al. Mother-level random effect in the association between PM2.5 and fetal growth: A population-based pregnancy cohort. Environ. Res. 210, (2022).

42.          Romm, K. F. et al. Drivers and Passengers in Vehicles Driven Under the Influence of Alcohol or Marijuana: Behavior Profiles and Risk Factors Among Young Adults in a Longitudinal Study. J. Stud. Alcohol Drugs 83, 342–351 (2022).

43.          Cahen-Peretz, A. et al. Long-term respiratory outcomes in early-term born offspring: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM 4, (2022).

44.          Skakkebæk, N. E. et al. Environmental factors in declining human fertility. Nat. Rev. Endocrinol. 18, 139–157 (2022).

45.          Abroms, L. et al. Anticipating IQOS market expansion in the United States. Tob. Prev. Cessat. 8, (2022).

46.          Bar-Zeev, Y. et al. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition. Nicotine Tob. Res. 24, 100–108 (2022).

47.          Nitzan, I. et al. Socio-demographic disparities in amblyopia prevalence among 1.5 million adolescents. Eur. J. Public Health 31, 1211–1217 (2021).

48.          Jørgensen, N. et al. Are worldwide sperm counts declining? Fertil. Steril. 116, 1457–1463 (2021).

49.          Dor-Haim, H., Katzburg, S., Revach, P., Levine, H. & Barak, S. The impact of COVID-19 lockdown on physical activity and weight gain among active adult population in Israel: a cross-sectional study. BMC Public Health 21, (2021).

50.          Bar-Zeev, Y. et al. Tobacco legislation reform and industry response in Israel. Tob. Control 30, e62–e64 (2021).

51.          Magen-Molho, H. et al. Air Pollution and Autism Spectrum Disorder in Israel: A Negative Control Analysis. Epidemiology 32, 773–780 (2021).

52.          Berg, C. J. et al. IQOS marketing in the US: The need to study the impact of FDA modified exposure authorization, marketing distribution channels, and potential targeting of consumers. Int. J. Environ. Res. Public Health 18, (2021).

53.          Tschernichovsky, R. et al. Height in adolescence as a risk factor for glioma subtypes: A nationwide retrospective cohort study of 2.2 million subjects. Neuro. Oncol. 23, 1383–1392 (2021).

54.          Negev, M. et al. Regional lessons from the COVID-19 outbreak in the Middle East: From infectious diseases to climate change adaptation. Sci. Total Environ. 768, (2021).

55.          Leventer-Roberts, M. et al. Environmental Tobacco Smoke Exposure Among Children by Urinary Biomarkers and Parent Report. Acad. Pediatr. 21, 663–669 (2021).

56.          Levinger, N. et al. Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration. Eur. J. Ophthalmol. 31, 1094–1100 (2021).

57.          Eliasi, E. et al. The Association Between Keratoconus and Body Mass Index: A Population-Based Cross-Sectional Study Among Half a Million Adolescents. Am. J. Ophthalmol. 224, 200–206 (2021).

58.          Meiner, Z. et al. Risk factors for functional deterioration in a cohort with late effects of poliomyelitis: A ten-year follow-up study. NeuroRehabilitation 49, 491–499 (2021).

59.          Stein-Zamir, C. & Levine, H. The measles outbreak in Israel in 2018-19: lessons for COVID-19 pandemic. Hum. Vaccines Immunother. 17, 2085–2089 (2021).

60.          Milic, M. et al. Is exposure to indoor secondhand smoke associated with poor mental health? Results from non-conflict and post-conflict setting. Psychol. Heal. Med. 26, 1294–1307 (2021).

61.          Hochman, A. et al. The relationship between cyclonic weather regimes and seasonal influenza over the Eastern Mediterranean. Sci. Total Environ. 750, (2021).

62.          Masarwa, R., Perlman, A., Levine, H. & Matok, I. Masarwa et al. Respond to “The Disillusionment of Developmental Origins of Health and Disease (DOHaD) Epidemiology”. Am. J. Epidemiol. 189, 6–7 (2021).

63.          Bui, L. V et al. Estimation of the incubation period of COVID-19 in Vietnam. PLoS One 15, (2020).

64.          Hochman, A. et al. Interdisciplinary regional collaboration for public health adaptation to climate change in the eastern mediterranean. Bull. Am. Meteorol. Soc. 101, E1685–E1689 (2020).

65.          Ben-Zion Berliner, M. et al. Height as a risk factor in meningioma: A study of 2 million Israeli adolescents. BMC Cancer 20, (2020).

66.          Magen-Molho, H. et al. Spatiotemporal distribution of autism spectrum disorder prevalence among birth cohorts during 2000–2011 in Israel. Ann. Epidemiol. 48, 1–8 (2020).

67.          Keinan Boker, L. et al. Adolescent characteristics and incidence of pre-malignant disease and invasive tumors of the cervix. Int. J. Gynecol. Cancer 30, 959–968 (2020).

68.          Atias, D. et al. Community Vs. hospital HIV testing sites in Jerusalem, Israel-who’s tested and who’s at risk? Isr. J. Health Policy Res. 9, (2020).

69.          Megreli, J., Barak, A., Bez, M., Bez, D. & Levine, H. Association of Myopia with cognitive function among one million adolescents. BMC Public Health 20, (2020).

70.          Rosen, L., Kislev, S., Bar-Zeev, Y. & Levine, H. Historic tobacco legislation in Israel: A moment to celebrate. Isr. J. Health Policy Res. 9, (2020).

71.          Yust-Katz, S. et al. Echoes from the past- changing associations between brain tumors and ethnicity. J. Neurol. Sci. 408, (2020).

72.          Milic, M. et al. Tobacco smoking and health-related quality of life among university students: Mediating effect of depression. PLoS One 15, (2020).

73.          Berg, C. J., Bar-Zeev, Y. & Levine, H. Informing iQOS Regulations in the United States: A Synthesis of What We Know. SAGE Open 10, (2020).

74.          Segev, A., Weisskopf, M. G., Levine, H., Pinto, O. & Raz, R. Incidence time trends and socioeconomic factors in the observed incidence of autism spectrum disorder in israel: A nationwide nested case–control study. Autism Res. 12, 1870–1879 (2019).

75.          Gold, D. D. et al. Door To Detorsion Time Determines Testicular Survival. Urology 133, 211–215 (2019).

76.          Bez, D. et al. Association between Type of Educational System and Prevalence and Severity of Myopia among Male Adolescents in Israel. JAMA Ophthalmol. 137, 887–893 (2019).

77.          Bary-Weisberg, D. et al. Feasibility of a text-messaging smoking cessation program for soldiers in Israel. BMC Public Health 19, (2019).

78.          Negev, M. et al. Adaptation of health systems to climate-related migration in Sub-Saharan Africa: Closing the gap. Int. J. Hyg. Environ. Health 222, 311–314 (2019).

79.          Bar-Zeev, Y., Levine, H., Rubinstein, G., Khateb, I. & Berg, C. J. IQOS point-of-sale marketing strategies in Israel: A pilot study. Isr. J. Health Policy Res. 8, (2019).

80.          Rottenberg, Y., Zick, A. & Levine, H. Temporal trends of geographic variation in mortality following cancer diagnosis: A population-based study. BMC Public Health 19, (2019).

81.          Matok, I., Masarwa, R., Levine, H. & Perlman, A. FOUR AUTHORS REPLY. Am. J. Epidemiol. 187, 2718 (2018).

82.          Bui, L. V, Mor, Z., Chemtob, D., Ha, S. T. & Levine, H. Use of geographically weighted poisson regression to examine the effect of distance on tuberculosis incidence: A case study in Nam Dinh, Vietnam. PLoS One 13, (2018).

83.          Levine, H. et al. Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, Sweden. Basic Clin. Androl. 28, (2018).

84.          Masarwa, R. et al. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: A systematic review,meta-analysis, and meta-regression analysis of cohort studies. Am. J. Epidemiol. 187, 1817–1827 (2018).

85.          Getachew, B. et al. Perceptions of alternative tobacco products, anti-tobacco media, and tobacco regulation among young adults: A qualitative study. Am. J. Health Behav. 42, 118–130 (2018).

86.          Twig, G. et al. Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents. Int. J. Obes. 42, 801–807 (2018).

87.          Raz, R. et al. Traffic-Related Air Pollution and Autism Spectrum Disorder: A Population-Based Nested Case-Control Study in Israel. Am. J. Epidemiol. 187, 717–725 (2018).

88.          Keinan-Boker, L., Levine, H., Leiba, A., Derazne, E. & Kark, J. D. Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men. Int. J. Cancer 142, 910–918 (2018).

89.          Sun, X. et al. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004–2016. Vaccine 36, 1279–1284 (2018).

90.          Golan, R. et al. Environmental exposures and fetal growth: The Haifa pregnancy cohort study David Stieb, Cecile Boot, Michelle Turner, Osmar Zaiane. BMC Public Health 18, (2018).

91.          Zarka, S. et al. Smoking behavior change during compulsory military service in Israel, 1987-2011. Nicotine Tob. Res. 19, 1322–1329 (2017).

92.          Levine, H. et al. Paternal age and risk of testicular germ cell tumors: a cohort study of 1,000,000 men. Andrology 5, 1124–1130 (2017).

93.          Levine, H. et al. Temporal trends in sperm count: A systematic review and meta-regression analysis. Hum. Reprod. Update 23, 646–659 (2017).

94.          Kopel, E., Davidovitch, N. & Levine, H. Using all means to protect public health in Israel from emerging tobacco products. Am. J. Public Health 107, 1599–1600 (2017).

95.          Twig, G. et al. Adolescent body mass index and cardiovascular disease-specific mortality by midlife. J. Clin. Endocrinol. Metab. 102, 3011–3020 (2017).

96.          Levine, H. et al. Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish Israelis. Leuk. Lymphoma 58, 959–968 (2017).

97.          Shamriz, O. et al. Higher body mass index in 16–19 year-old Jewish Adolescents of North African, Middle Eastern and European Origins is a Predictor of Acute Myeloid Leukemia: a cohort of 2.3 million Israelis. Cancer Causes Control 28, 331–339 (2017).

98.          Matok, I. et al. Association of Acetaminophen and Ibuprofen Use With Wheezing in Children With Acute Febrile Illness. Ann. Pharmacother. 51, 239–244 (2017).

99.          Rottenberg, Y. et al. Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents. Int. J. Cancer 140, 1060–1067 (2017).

100.        Berman, T., Goldsmith, R., Levine, H. & Grotto, I. Human biomonitoring in Israel: Recent results and lessons learned. Int. J. Hyg. Environ. Health 220, 6–12 (2017).

101.        Kopel, E., Davidovitch, N. & Levine, H. Lessons from a 2016 large-scale contamination of cereals with Salmonella altona in Israel. Am. J. Public Health 107, 243–245 (2017).

102.        Adebayo, G., Neumark, Y., Gesser-Edelsburg, A., Ahmad, W. A. & Levine, H. Zika pandemic online trends, incidence and health risk communication: A time trend study. BMJ Glob. Heal. 2, (2017).

103.        Twig, G. et al. BMI at age 17 years and diabetes mortality in midlife: A nationwide cohort of 2.3 million adolescents. Diabetes Care 39, 1996–2003 (2016).

104.        Halperin, T. et al. Molecular characterization and antibiotic resistance of group G streptococci in Israel: comparison of invasive, non-invasive and carriage isolates. Eur. J. Clin. Microbiol. Infect. Dis. 35, 1649–1654 (2016).

105.        Martino-Andrade, A. J. et al. Timing of prenatal phthalate exposure in relation to genital endpoints in male newborns. Andrology 4, 585–593 (2016).

106.        Thurston, S. W. et al. Phthalate exposure and semen quality in fertile US men. Andrology 4, 632–638 (2016).

107.        Keinan-Boker, L., Levine, H., Derazne, E., Molina-Hazan, V. & Kark, J. D. Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women. Breast Cancer Res. Treat. 158, 157–167 (2016).

108.        Twig, G. et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N. Engl. J. Med. 374, 2430–2440 (2016).

109.        Feldman, I., Donchin, M. & Levine, H. A smoke-free medical campus in Jerusalem: Data for action. Isr. J. Health Policy Res. 5, (2016).

110.        Chiu, Y.-H. et al. Intake of fruits and vegetables with lowto- moderate pesticide residues is positively associated with semen-quality parameters among young healthy men. J. Nutr. 146, 1084–1092 (2016).

111.        Leiba, M. et al. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years. Cancer 122, 1068–1077 (2016).

112.        Leiba, A. et al. Hypertension in late adolescence and cardiovascular mortality in midlife: a cohort study of 2.3 million 16- to 19-year-old examinees. Pediatr. Nephrol. 31, 485–492 (2016).

113.        Le Moal, J. et al. Toward a multi-country monitoring system of reproductive health in the context of endocrine disrupting chemical exposure. Eur. J. Public Health 26, 76–83 (2016).

114.        Tasher, D. et al. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience. Vaccine 34, 299–301 (2016).

115.        Hartal, M. et al. Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy. Vaccine 33, 4878–4885 (2015).

116.        Levine, H. et al. Neglect of skin wounds and the risk of becoming a Staphylococcus aureus nasal carrier: a cohort study. BMC Public Health 15, (2015).

117.        Abroms, L., Hershcovitz, R., Boal, A. & Levine, H. Feasibility and Acceptability of a Text Messaging Program for Smoking Cessation in Israel. J. Health Commun. 20, 903–909 (2015).

118.        Beenstock, M., Raz, R. & Levine, H. Birth gap and the recurrence risk of autism spectrum disorders: A population-based cohort study. Res. Autism Spectr. Disord. 17, 86–94 (2015).

119.        Raz, R., Weisskopf, M. G., Davidovitch, M., Pinto, O. & Levine, H. Differences in Autism Spectrum Disorders Incidence by Sub-Populations in Israel 1992–2009: A Total Population Study. J. Autism Dev. Disord. 45, 1062–1069 (2015).

120.        Levine, H. & Swan, S. H. Is dietary pesticide exposure related to semen quality? Positive evidence from men attending a fertility clinic. Hum. Reprod. 30, 1287–1289 (2015).

121.        Levine, H., Kopel, E., Anis, E., Givon-Lavi, N. & Dagan, R. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012. Eurosurveillance 20, (2015).

122.        Levine, H. et al. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel. Hum. Vaccines Immunother. 11, 1400–1405 (2015).

123.        Levine, H. et al. Urinary concentrations of polycyclic aromatic hydrocarbons in Israeli adults: Demographic and life-style predictors. Int. J. Hyg. Environ. Health 218, 123–131 (2015).

124.        Schwartz, I. et al. The association between post-polio symptoms as measured by the Index of Post-Polio Sequelae and self-reported functional status. J. Neurol. Sci. 345, 87–91 (2014).

125.        Rosen, L. et al. Smoking initiation among Israeli adolescents: A 24-year time-to-event analysis. Prev. Med. (Baltim). 65, 141–147 (2014).

126.        Levine, H. et al. Time trends of viral meningitis among young adults in Israel: 1978-2012. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1149–1153 (2014).

127.        Berman, T. et al. Demographic and dietary predictors of urinary bisphenol A concentrations in adults in Israel. Int. J. Hyg. Environ. Health 217, 638–644 (2014).

128.        Levine, H. et al. Exposure to tobacco smoke based on urinary cotinine levels among Israeli smoking and nonsmoking adults: A cross-sectional analysis of the first Israeli human biomonitoring study. BMC Public Health 13, (2013).

129.        Moran-Gilad, J. et al. Postexposure prophylaxis of tick-borne relapsing fever: Lessons learned from recent outbreaks in Israel. Vector-Borne Zoonotic Dis. 13, 791–797 (2013).

130.        Rais, A. et al. Varicocoele among 1 300 000 Israeli adolescent males: Time trends and association with body mass index. Andrology 1, 663–669 (2013).

131.        Levine, H. et al. Country of origin, age at migration and risk of cutaneous melanoma: A migrant cohort study of 1,100,000 Israeli men. Int. J. Cancer 133, 486–494 (2013).

132.        Mimouni, D., Levine, H., Ferber, A. T., Rajuan-Galor, I. & Huerta-Hartal, M. Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979-2010. Hum. Vaccines Immunother. 9, 1303–1307 (2013).

133.        Levine, H. et al. Risk of germ cell testicular cancer according to origin: A migrant cohort study in 1,100,000 Israeli men. Int. J. Cancer 132, 1878–1885 (2013).

134.        Ereqat, S. et al. First-time detection of Mycobacterium bovis in livestock tissues and milk in the West Bank, Palestinian Territories. PLoS Negl. Trop. Dis. 7, (2013).

135.        Berman, T. et al. Urinary concentrations of organophosphate pesticide metabolites in adults in Israel: Demographic and dietary predictors. Environ. Int. 60, 183–189 (2013).

136.        Berman, T. et al. Urinary concentrations of environmental contaminants and phytoestrogens in adults in Israel. Environ. Int. 59, 478–484 (2013).

137.        Levine, H. et al. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel. Vaccine 30, 7260–7264 (2012).

138.        Levine, H. et al. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Ann. Epidemiol. 22, 783–788 (2012).

139.        Levine, H. et al. Dynamics of Pneumococcal Acquisition and Carriage in Young Adults during Training in Confined Settings in Israel. PLoS One 7, (2012).

140.        Berman, T., Levine, H., Gamzu, R. & Grotto, I. Trends in reproductive health in Israel: Implications for environmental health policy. Isr. J. Health Policy Res. 1, (2012).

141.        Levine, H. et al. Smoking and other correlates of health care services utilization among mandatory military recruits in Israel. Nicotine Tob. Res. 14, 742–750 (2012).

142.        Levine, H. et al. Secular and seasonal trends of infectious mononucleosis among young adults in Israel: 1978-2009. Eur. J. Clin. Microbiol. Infect. Dis. 31, 757–760 (2012).

143.        Negev, M., Levine, H., Davidovitch, N., Bhatia, R. & Mindell, J. Integration of health and environment through health impact assessment: Cases from three continents. Environ. Res. 114, 60–67 (2012).

144.        Levine, H. et al. Transmission of Streptococcus pneumoniae in adults may occur through saliva. Epidemiol. Infect. 140, 561–565 (2012).

145.        Levine, H., Balicer, R. D., Laor, D. & Grotto, I. Challenges and opportunities in the Israeli 2009 pandemic influenza vaccination program. Hum. Vaccin. 7, (2011).

146.        Levine, H. et al. Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy. Vaccine 29, 2785–2790 (2011).

147.        Levine, H., Rishpon, S., Huerta-Hartal, M. & Davidovitch, N. Preventing mumps outbreaks in confined settings: Comprehensive ring vaccination as a containment strategy. Hum. Vaccin. 7, 1389–1393 (2011).

148.        Balicer, R. D. et al. Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination. Vaccine 28, 5591–5596 (2010).

149.        Mimouni, D. et al. Secular trends of gonorrhea in young adults in Israel: Three decades of follow-up. Eur. J. Clin. Microbiol. Infect. Dis. 29, 1111–1115 (2010).

150.        Balicer, R. D. et al. Post exposure prophylaxis of tick-borne relapsing fever. Eur. J. Clin. Microbiol. Infect. Dis. 29, 253–258 (2010).

151.        Hazan, V. M. et al. The military role in a flu pandemic. Harefuah 149, 9-13,64 (2010).

152.        Grotto, I., Levine, H. & Balicer, R. D. Pandemic influenza vaccines: From the lab to ethical policy making. Harefuah 148, 672–676 (2009).

153.        Mimouni, D. et al. Trends in the epidemiology of cutaneous leishmaniasis in a young adult population in Israel: A long-term survey. Int. J. Dermatol. 48, 611–613 (2009).

154.        Levine, H. Noble prize for the discoverers of Helicobacter pylori - The overlooked bacteria. Harefuah 144, 755-758+824 (2005).